SironRX Therapeutics

Cleveland 200, Cleveland Clinic, Healthcare IT, Jumpstart Evergreen, Jumpstart Focus, Jumpstart Next, North Coast Angel Fund
SironRX Therapeutics was developing novel therapies to promote dermal wound repair and reduce scarring. The company’s therapeutic platform was based on the delivery of Stromal cell-Derived Factor 1 (SDF-1), which has been shown to promote tissue repair by recruiting stem cells to the damaged organ. SDF-1 has also been shown to prevent cell death and promote new blood vessel formation. SironRx Therapeutics has received investment from the North Coast Angel Fund, Cleveland Clinic, and Jumpstart Next, Evergreen, and Focus Funds.
Read More

Cleveland HeartLab

Cleveland 200, Cleveland Clinic, Jumpstart Evergreen, Mutual Capital Partners
Cleveland HeartLab is a leading diagnostics company specializing in the detection, prevention, and management of cardiovascular disease from a proprietary product pipeline licensed exclusively from the Cleveland Clinic, the global leader in cardiac health. Through its reliable group of biomarkers, Cleveland HeartLab is recognized as a leader in defining individual cardiovascular risk with the goal of educating and serving physicians, reference laboratories, wellness providers, and ultimately the individuals behind the tests. Cleveland HeartLab has received investments from the Cleveland Clinic, the Jumpstart Evergreen fund, and Mutual Capital Partners.
Read More